Navigation Links
Exelixis Announces Senior Management Promotions
Date:1/4/2008

-Pamela A. Simonton Promoted to Executive Vice President and General

Counsel- -Gisela M. Schwab Promoted to Executive Vice President and Chief Medical

Officer-

SOUTH SAN FRANCISCO, Calif., Jan. 4 /PRNewswire-FirstCall/ -- Exelixis, Inc. (Nasdaq: EXEL) today announced promotions for two members of its senior management team. Pamela A. Simonton, Senior Vice President of Patents and Licensing, has been promoted to Executive Vice President and General Counsel and Dr. Gisela M. Schwab, Senior Vice President and Chief Medical Officer, has been promoted to Executive Vice President and Chief Medical Officer.

"I am happy to promote both Pamela and Gisela. Both have played key roles in Exelixis' accomplishments, and both promotions are well-deserved. Pamela will now have responsibility for all corporate legal matters and legal services in support of Exelixis' business and corporate objectives," said George Scangos, Ph.D., President and Chief Executive Officer of Exelixis. "Pamela has been responsible for all of the patent and licensing activity since her arrival in 2000 and has played a major role in our partnering activities as well. Dr. Schwab will continue to lead the Development Organization as we plan to move 3 compounds into pivotal trials in the first half of 2008."

Ms. Simonton has served as Senior Vice President, Patents and Licensing, since January 2004. Previously, she served as Vice President of Corporate Technology Development from April 2000 through December 2003. From July 1996 to April 2000, she served as Vice President, Licensing and Acquisitions for Bayer Corporation's Pharmaceutical Division. From September 1994 to July 1996, Ms. Simont
'/>"/>

SOURCE Exelixis, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Exelixis Announces January 10 Webcast of Presentation at the 26th Annual JPMorgan Healthcare Conference
2. Exelixis Submits XL139 Diligence Report to Bristol-Myers Squibb
3. Reminder: Exelixis Announces December 5 Webcast of Its Third Annual R&D Day
4. Exelixis Announces November 28 Webcast of Presentation at the Lazard Capital Markets Fourth Annual Healthcare Conference
5. Exelixis Announces November 27 Webcast of Presentation at the 19th Annual Piper Jaffray Health Care Conference
6. Exelixis Announces December 5 Webcast of Its Third Annual R&D Day
7. Exelixis Sells 80% Stake in Artemis to Taconic
8. Exelixis Announces Third Quarter 2007 Financial Results and Business Update
9. Exelixis Announces November 5 Webcast of its 2007 Third Quarter Financial Results Conference Call
10. Exelixis Submits XL880 Diligence Report to GlaxoSmithKline
11. Exelixis Announces Closing of Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/17/2014)... , July 17, 2014  Vanda Pharmaceuticals Inc. ... focused on the development and commercialization of products for ... it will release results for the second quarter of ... opens. The Company will host a ... 7, 2014, during which Vanda management will discuss the ...
(Date:7/17/2014)...  Prana Biotechnology (NASDAQ: PRAN ; ASX: ... development program for Alzheimer,s disease. Professor ... Mental Health, The University of Melbourne, will today include ... in his presentation at the Alzheimer,s Association International Conference ... The presentation is entitled: "How to change and ...
(Date:7/17/2014)... all know, some optical devices can only work with ... polarizer is necessary to shift the polarization direction of ... half-wave plate, which constructed out of a birefringent material ... half-wave plate depends on the thickness of the crystal, ... a half-wave plate is difficulty to integrate on circuits. ...
(Date:7/17/2014)... , July 17, 2014  Exelixis, Inc. (Nasdaq: ... company. EXEL developed two cancer treatments cabozantinib (Cabo, Cometriq) ... active component. The company has a partnership with Roche ... to earn approval in the treatment of melanoma by ... week. Cabo is marketed and distributed in the U.S. ...
Breaking Biology Technology:Vanda Pharmaceuticals to Announce Second Quarter 2014 Financial Results on August 7, 2014 2Prana Alzheimer's disease Development Program update 2Prana Alzheimer's disease Development Program update 3Prana Alzheimer's disease Development Program update 4Prana Alzheimer's disease Development Program update 5Exelixis, Inc., Analyst Report; The Upside Potential is Worth the Risk by BrokerBank Securities, Inc. 2
... Inc. (TSX:SDI), a company developing products for the ... International Symposium on Intensive Care and Emergency Medicine ... feature a key scientific symposium entitled, "The Role ... thought leaders in the field of sepsis. Presentations ...
... - Up to $50 Million Potential Milestones plus Double ... Host Conference Call at 11:00 a.m. ET Today - ... Amex: NBY ), a mid-stage biopharmaceutical company ... of a wide range of infections without causing resistance, ...
... 23, 2009 Reston, Va. The American Institute ... for Composites (ASC) congratulate the winners of the inaugural ... Distinguished Professor of Mechanical and Aerospace Engineering at the ... A. Armstrong Distinguished Professor of Aeronautical and Astronautical Engineering ...
Cached Biology Technology:Spectral announces presentations at the 29TH International Symposium on Intensive Care and Emergency Medicine focusing on the role of endotoxin 2NovaBay and Galderma Enter Into Global Agreement to Develop and Commercialize NovaBay's Novel Aganocide Drugs for Major Dermatological Conditions 2NovaBay and Galderma Enter Into Global Agreement to Develop and Commercialize NovaBay's Novel Aganocide Drugs for Major Dermatological Conditions 3NovaBay and Galderma Enter Into Global Agreement to Develop and Commercialize NovaBay's Novel Aganocide Drugs for Major Dermatological Conditions 4NovaBay and Galderma Enter Into Global Agreement to Develop and Commercialize NovaBay's Novel Aganocide Drugs for Major Dermatological Conditions 5NovaBay and Galderma Enter Into Global Agreement to Develop and Commercialize NovaBay's Novel Aganocide Drugs for Major Dermatological Conditions 6Professors Raphael Haftka and C. T. Sun to receive AIAA-ASC James H. Starnes Jr. Award 2
(Date:7/21/2014)... and think, "Of course! Why didn,t I think of ... own invention, sparking ideas and building possibilities. This type ... Station Program Science Office,s new 15-book Researcher,s Guide Series. ... in orbit, their mental wheels may begin to speed ... propose new research and potentially make discoveries that they ...
(Date:7/21/2014)... Lgar,s team at the INRS nergie Matriaux Tlcommunications ... a spatial and temporal resolution greatly exceeding that ... a femtosecond laser source to shoot a molecular ... vinylidene. An article presenting the advancement was recently ... . , "The approach we developed combines ...
(Date:7/21/2014)... -- Why does the word "dog" have meaning? If ... friend understand you? , Kansas State University philosopher Elliott ... his latest research, which focuses on long-standing philosophical questions ... two other philosophers and a mathematician are collaborating to ... acquires meaning. , "If I order a cappuccino at ...
Breaking Biology News(10 mins):International Space Station researcher guides aim to maximize science 2International Space Station researcher guides aim to maximize science 3International Space Station researcher guides aim to maximize science 4Philosopher uses game theory to understand how words, actions acquire meaning 2
... [Brown University] A computerized epidemiological model of the spread ... California in 2005 successfully predicted where 81.6 percent of human ... where the risk of infection turned out to be 39 ... research. The DYCAST software used in those predictions is now ...
... cells is a well-oiled machine with tiny protein motors hauling ... molecular motors are responsible for a variety of critical transport ... can put themselves into "energy save mode" to conserve cellular ... the cell, and when. A new study ...
... may not sound very glamorous, a new method of ... news for both confined animal operations and environmental groups, ... The method uses gas-permeable membrane technology that tests have ... in liquid manure in 20 days. The removed ammonium ...
Cached Biology News:Software predicted risk in California West Nile virus epidemic 2Carnegie Mellon scientists discover how molecular motors go into 'energy save mode' 2Carnegie Mellon scientists discover how molecular motors go into 'energy save mode' 3New technology could capture ammonia from liquid manure 2New technology could capture ammonia from liquid manure 3
... fast and reliable automation for today's ... development laboratories. Staccato Mini-Workstations offer the ... basic liquid handling and material management ... either Caliper's time proven CLARA™ assay ...
Experion StdSens chips are the microfluidic chips used to perform standard-sensitivity RNA analysis (nanogram levels) with the Experion automated electrophoresis system. Each chip has the capacity to...
... If particles in the submicron range ... development process, measurement and control of particle ... an analyzer that can reliably detect the ... The N5 Submicron Particle Size Analyzer uses ...
...
Biology Products: